TISSUE AND ORGAN TRANSPLANTATION MARKET ANALYSIS

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ TISSUE AND ORGAN TRANSPLANTATION MARKET ANALYSIS

2. TISSUE AND ORGAN TRANSPLANTATION MARKET ANALYSIS Tissue and Organ Transplantation Market, by Product Type (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Application (Organ Transplantation and Tissue Transplantation ), by End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

3. Figure 1. Global Tissue and Organ Transplantation Market Share (%) Analysis, By Application, 2020

4. The global tissue and organ transplantation market is estimated to be valued at US$ 13.9  Billion in 2020 and is expected to exhibit a CAGR of 9.1%  during the forecast period (2020-2027). • Increasing number of people suffering from organ failure is expected to drive growth of the global tissue and organ transplantation market • According to the World Health Organization (WHO) Global Observatory on Donation and Transplantation 2014, around 119,873 organs are transplanted annually worldwide. Moreover, increasing number of chronic diseases leading to organ failure and habits such as smoking and drinking further leading to organ disability are expected to fuel growth of the tissue and organ transplantation market over the forecast period. For instance, according to the Health Resources and Services Administration, till May 2017, there were around 117,829 patients waiting for organ transplants in the U.S., among which about 97,610 were waiting for kidney transplants. However, only 11,061 transplant procedures were performed from January to April 2017. Thus, increasing number of people awaiting organ and tissue transplant and increasing mortality rate due to the inadequate organ and tissue for transplantation might create opportunities in the tissue and organ transplantation market.

6. Tissue and Organ Transplantation Market- Restraints • The shortage of organs for the treatment of organ failure is expected to hamper the global tissue and organ transplantation market growth. There is a huge gap between demand and supply of organs for organ failure treatment. For instance, according to the U.S. Department of Health & Human Services, in 2019, there were around 43,201 patients with kidney transplant requirements in the U.S., however, only 23,401 kidney transplant procedures were performed. • Furthermore, according to the World Health Resources & Services Administration, 17 people die each day waiting for an organ transplant in the U.S.

7. Tissue and Organ Transplantation Market– Regional Analysis • North America accounted for the largest market share in 2019 in the tissue and organ transplantation market, owing to increasing number of organ transplant surgeries in the U.S. For instance, according to the Mayo Foundation for Medical Education and Research (MFMER), in 2017, around 8,000 liver transplants were performed in the U.S. among both adults and children. Of those, around 360 involved livers from living donors. At the same time, around 11,500 people were registered on the waiting list for a liver transplant. • Furthermore, Asia Pacific is expected to witness the fastest growth during the forecast period, owing to increasing prevalence of chronic diseases. For instance, according to the global burden of disease study 2016, the estimated prevalence of cardiovascular diseases (CVDs) in India was estimated to be 54.5 million. One in 4 deaths in India is due to CVDs including ischemic heart disease and stroke.

8. Figure 2. Global Tissue and Organ Transplantation Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

9. Tissue and Organ Transplantation Market- Competitive Landscape • Key players operating in the tissue and organ transplantation market include CryoLife, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, BiolifeSolutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical.

10. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • CMI Services • CMI Latest Insights • CMI Blogs • CMI Press Releases

11. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

12. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/